L'institut Du Thorax
Research facility
Location:
Nantes,
France (FR)
ROR: https://ror.org/049kkt456
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial (2024)
Pratley RE, Tuttle KR, Rossing P, Rasmussen S, Perkovic V, Nielsen OW, Mann JF, et al.
Journal article
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial (2024)
Mann JF, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, et al.
Journal article
De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delay (2024)
Ha T, Morgan A, Bartos MN, Beatty K, Cogné B, Braun D, Gerber CB, et al.
Journal article